1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. PENUMBRA INC
350.78 0.29 (0.08%)
3.3M

XNYS 16 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Analyst Downgrade
Baird downgrades Penumbra to a 'Neutral' rating; considers it overvalued compared to its Fair Value See details

Penumbra Inc - PEN - stock price prediction, stock price target, analyst ratings from 18 analysts

Penumbra Inc has a share price target of US$ 346, revenue growth forecast of 15.7%, and profit growth estimate of 1084.9% for FY25, based on top 18 analyst calls.